Surgery Partners, Inc.SGRYNASDAQ
Loading
SGRY Revenue Growth (YoY Quarterly)•+2.38%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+2.38%
-4.2pp
-9.16%
-19.2pp
+83.29%
-181.6pp
-13.30%
-86.9pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.79%
+0.2pp
+0.79%
+0.2pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +17.54% | +8.17% | +8.41% | +6.63% | +2.38% |
| Gross Profit Growth | +20.66% | +4.25% | +9.15% | +10.03% | -9.16% |
| EBITDA Growth | +21.51% | -10.48% | +27.09% | +264.90% | +83.29% |
| Operating Income Growth | +25.35% | -18.55% | +31.72% | +73.56% | -13.30% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.35% | +0.50% | +0.67% | +0.60% | +0.79% |
| Weighted Average Shares Diluted Growth | +0.35% | +0.50% | +0.67% | +0.60% | +0.79% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +77.96% | -85.26% | -1.81% | +28.22% | -7.18% |
| Free Cash Flow Growth | +108.18% | -184.77% | +3.58% | +41.78% | +1.68% |
| Receivables Growth | +16.66% | +15.44% | +7.59% | +6.70% | +3.99% |
| Inventory Growth | +17.55% | +14.42% | +7.91% | +12.56% | +9.28% |
| Asset Growth | +14.74% | +13.96% | +6.23% | +5.47% | +4.46% |
| Book Value per Share Growth | -10.25% | -11.97% | -11.05% | -9.35% | -5.04% |
| Debt Growth | +20.96% | +22.66% | +13.11% | +10.00% | +8.68% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +72.25% | +8.43% | -10.42% | +1008.90% | +252.22% |
1 / 4